2021-11-16-世界卫生组织-Cervical_cancer_Angola_2021_country_profile_1页_65kb

Angola Cervical Cancer Profile Summary

Morbidity and Mortality

• Cervical Cancer Incidence (2020): Age-standardized rate at 37.6 per 100,000 women.
• Cervical Cancer Deaths (2019): 104,000 female deaths.
• Cumulative Risk (0-74): 4.2%.
• Mortality-to-Incidence Ratio (2020): 0.61.
• Cancer Registry: Existed in 2021.
• Overall Trends: High disease burden, low in registry completeness.

Primary Prevention

• HPV Vaccination: Not included in the national schedule. Coverage among girls for first dose is <1%, with 44% reporting program, but overall low uptake.
• Other Risk Factors: High tobacco use at 37.6%. HIV incidence and condom use data incomplete.
• Vaccine Status: Only limited evidence of vaccination up to age 15; not widespread.

Secondary Prevention

• Screening: No national cervical cancer screening program in place.
• Detection and Referral: Inadequate systems; referral systems from primary to tertiary care unclear or absent based on data.

Treatment and Supportive Care

• Guidelines and Infrastructure: National guidelines exist but implementation challenges persist.
• Treatment Resources: Low capacity for radiotherapy (1.32 units/10,000 patients), chemotherapy, and diagnostic services are under-resourced.
• Staff Levels: Limited medical and specialized personnel available.

WHO Elimination Strategy Progress

• Key Indicators: Missed targets for HPV vaccination and screening based on available data, with HPV program coverage derestricted at only 44% and screening rates low (20% in last 5 years).
• Population Statistics (2019): Total female population 16,080,000; high mortality rate highlights need for interventions.
• Overall Status: Significant challenges in prevention, screening, and treatment resource availability for cervical cancer elimination by 2030.